KUALA LUMPUR, Sept 19 -- PRA Health Sciences, a full-service global contract research organisation has launched Symphony Health’s new national market measurement tool, Metys™.
Symphony Health is a wholly-owned subsidiary of PRA Health Sciences, according to a statement.
Metys is the only completely integrated, all-in-one market research solution available from a contract research organisation, delivering pharmaceutical market analytics and intelligence that is both timely and comprehensive.
“PRA and Symphony Health have developed a solution that quickly and efficiently brings all data to the clients’ fingertips within the Metys™ platform,” said Symphony Health president, Doug Fulling.
“This offering affirms our commitment to serving our clients at the highest level with tools that will move their businesses forward, while also reinforcing our culture of innovation and excellence.”
Powered by IDV®, Metys intelligently integrates prescriber, payer and patient data assets. Source of business, managed care and other key metrics are also included and provide a complete picture of market activity.
-- BERNAMA
No comments:
Post a Comment